新兴的针对SARS-CoV-2的抗尖端单克隆抗体
Eloy E Ordaya1, Raymund R Razonable1
1Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, MN, USA.
Expert opinion on biological therapy
|March 3, 2024
概括
新型抗尖峰单克隆抗体 (mAbs) 显示出预防和治疗COVID-19的前景,特别是在免疫受损的个体中. 目前正在进行的研究重点是设计这些mAbs以对抗不断演变的SARS-CoV-2变种并确保持续的疗效.
科学领域:
- 免疫学和病毒学
- 开发治疗性抗体 开发治疗性抗体
背景情况:
- 以前授权的COVID-19抗尖峰单克隆抗体 (mAbs) 已不再对当前的SARS-CoV-2 Omicron变种有效.
- 这使得免疫功能受损的患者无法使用它们,而这些患者以前从中受益.
研究的目的:
- 总结早期临床发展中的新兴抗尖峰单克隆抗体 (mAbs).
- 评估它们的安全性,有效性和克服SARS-CoV-2演变的潜力.
主要方法:
- 对新型抗尖峰mAbs.的早期临床试验数据的审查.
- 对工程特征的分析,如延长半衰期和组合疗法.
- 评估新型的施用途径和应用,包括长期的COVID治疗.
主要成果:
- 新兴的mAbs在早期试验中显示出良好的耐受性和安全性.
- 工程策略旨在延长半衰期,并将mAbs结合起来以应对阻力.
- 新的应用包括吸入药物和长期COVID的治疗.
结论:
- 新型抗尖峰mAbs对免疫功能低下的患者有希望,建立在先前的成功基础上.
- 持续的SARS-CoV-2进化和逃生突变带来了挑战.
- 开发干预措施以确保这些病原体的持续活动对于未来的COVID-19管理至关重要.
相关概念视频
Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.


